Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000549220 | SCV000655112 | benign | Tumor predisposition syndrome 3 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000572211 | SCV000674404 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001662598 | SCV001881419 | benign | not provided | 2018-12-04 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821620 | SCV002066341 | benign | not specified | 2019-04-22 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000572211 | SCV002527135 | benign | Hereditary cancer-predisposing syndrome | 2022-01-23 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV001821620 | SCV002550120 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing |